Results 11 to 20 of about 1,971,309 (276)

Surgical Aortic Valve Replacement to Treat Prosthetic Valve Endocarditis After Valve-in-Valve Transcatheter Aortic Valve Replacement [PDF]

Cureus, 2023
Prosthetic valve endocarditis (PVE) is an uncommon complication after heart valve replacement surgery that can result in increased morbidity and mortality. Current guidelines for management of PVE recommend antibiotic therapy followed by surgical valve replacement. The number of aortic valve replacements is expected to rise in the coming years with the
Jena, Nihar, Patel, Kinjal, Desai, Ronak, Siddiqui, Nazia, Ahluwalia, Guneet, Halabi, Abdul R, Schwartz, Charles, Krishnan, Sandeep   +7 more
core   +4 more sources

The use of transcatheter aortic valve replacement vs surgical aortic valve replacement for the treatment of aortic stenosis

Research Reports in Clinical Cardiology, 2015
Hanna A Jensen, Lillian L Tsai, Vinod H Thourani Division of Cardiothoracic Surgery, Joseph B Whitehead Department of Surgery, Structural Heart and Valve Center, Emory University School of Medicine, Atlanta, GA, USA Abstract: Severe aortic stenosis (AS)
Jensen HA, Tsai LL, Thourani VH
doaj   +1 more source

Rationale and Design of the REPEAT Trial: A Multicenter Randomized Trial Comparing Redo Surgical Aortic Valve Replacement to Valve‐in‐Valve Transcatheter Aortic Valve Replacement

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Redo surgical aortic valve replacement (rSAVR) has for long been the therapeutic reference standard for degenerated surgical aortic bioprostheses.
Matthias Raschpichler, Suzanne de Waha, Stefan Blankenberg, Marcio A. Diniz, Emilia Bagiella, Annetine C. Gelijns, Vinicius F. Calsavara, Aakriti Gupta, Niklas Schofer, Tsuyoshi Kaneko, Mohamed Abdel‐Wahab, Holger Thiele, Raj Makkar, Michael A. Borger   +13 more
doaj   +2 more sources

Valve-in-Valve Transcatheter Aortic Valve Replacement Versus Redo Surgical Aortic Valve Replacement

JACC: Cardiovascular Interventions, 2021
sponsorship: Dr. Pibarot has echocardiography Core Laboratory contracts with Edwards Lifesciences, for which he receives no direct compensation. Dr. Clavel has computed tomography Core Laboratory contract with Edwards Lifesciences, for which she receives no direct compensation and received research grant from Medtronic.
Matthias, Raschpichler, Suzanne, de Waha-Thiele, Mohamed, Abdel-Wahab, Holger, Thiele, David, Holzhey, Michael, Borger   +5 more
  +7 more sources

Transcatheter and surgical aortic valve replacement in patients with bicuspid aortic valve [PDF]

Clinical Research in Cardiology, 2020
Abstract Objectives To compare the outcomes after surgical (SAVR) and transcatheter aortic valve replacement (TAVR) for severe stenosis of bicuspid aortic valve (BAV). Methods We evaluated the early and mid-term outcome of patients with stenotic BAV who underwent SAVR or ...
Annastiina Husso, Juhani Airaksinen, Tatu Juvonen, Mika Laine, Sebastian Dahlbacka, Marko Virtanen, Matti Niemelä, Timo Mäkikallio, Mikko Savontaus, Markku Eskola, Peter Raivio, Antti Valtola, Fausto Biancari   +12 more
openaire   +8 more sources

Resolution of severe secondary mitral valve regurgitation following aortic valve replacement in infective endocarditis [PDF]

, 2021
We present the case of a patient with infective endocarditis anesthetized for replacement of severely regurgitant aortic valve. Intraoperative transesophageal echocardiography revealed a new diagnosis of severe secondary mitral regurgitation.
Bruelisauer, Thomas, Samuel Hurni, Balthasar Eberle, Eberle, Balthasar, Erdoes, Gabor, Thomas Bruelisauer, Pasic, Miralem, Friess, Jan-Oliver, Jan Oliver Friess, Hurni, Samuel, Miralem Pasic, Gabor Erdoes   +11 more
core   +2 more sources

Transcatheter Aortic Valve Replacement With Self‐Expandable Supra‐Annular Valves for Degenerated Surgical Bioprostheses: Insights From Transcatheter Valve Therapy Registry

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Transcatheter aortic valve replacement with supra‐annular transcatheter heart valves has been adopted in patients with degenerated surgical aortic valves.
Luis Augusto P. Dallan, John K. Forrest, Michael J. Reardon, Wilson Y. Szeto, Isaac George, Susheel Kodali, Neal S. Kleiman, Steven J. Yakubov, Kendra J. Grubb, Fang Liu, Cristian Baeza, Guilherme F. Attizzani   +11 more
doaj   +1 more source

Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. [PDF]

, 2012
BACKGROUND: Transcatheter aortic-valve replacement (TAVR) is the recommended therapy for patients with severe aortic stenosis who are not suitable candidates for surgery. The outcomes beyond 1 year in such patients are not known.
Makkar, Raj R, Dewey, Todd M, Pocock, Stuart, Brown, David L, Pichard, Augusto D, Bowers, Bruce, Siegel, Robert J, Smith, Craig R, Webb, John G, Tuzcu, Murat, Moses, Jeffrey W, Williams, Matthew R, Babaliaros, Vasilis C, Thourani, Vinod H, Kapadia, Samir, Svensson, Lars G, Jilaihawi, Hasan, Kodali, Susheel, Bavaria, Joseph E, MD, Fontana, Gregory P, Akin, Jodi J, Douglas, Pamela S, Bavaria, Joseph E, Herrmann, Howard C, Leon, Martin B, PARTNER Trial Investigators, Anderson, William N   +26 more
core   +1 more source

The Midterm Impact of Transcatheter Aortic Valve Replacement on Surgical Aortic Valve Replacement in Michigan [PDF]

The Annals of Thoracic Surgery, 2016
We characterized the midterm impact of transcatheter aortic valve replacement (TAVR) on surgical aortic valve replacement (SAVR) volume, patient profiles, and outcomes in Michigan.We analyzed data obtained after SAVR (n = 15,288) and TAVR (n = 1,783) using the Michigan Society of Thoracic and Cardiovascular Surgery Quality Collaborative from 2006 to ...
Himanshu J, Patel, Morley A, Herbert, Gaetano, Paone, John C, Heiser, Francis L, Shannon, Patricia F, Theurer, Gail F, Bell, Richard L, Prager   +7 more
openaire   +2 more sources

Transcatheter Aortic Valve Implantation in Dialysis Patients [PDF]

, 2012
Background/Aims: Transcatheter aortic valve implantation (TAVI) has emerged as a new therapeutic option for high-risk patients. However, dialysis patients were excluded from all previous studies.
Wessely, Matthias, Schoenermarck, Ulf, Rau, Simon, Fischereder, Michael, Steinbeck, Gerhard, Kupatt, Christian, Lange, Philipp   +6 more
core   +1 more source